Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 14/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9508824 | 0.95 | ACACB (0.46) | ACACBLMNAKCNH2HRH3 | |
| SCHEMBL9512341 | 0.92 | ACACB (0.45) | ACACBLMNAHRH3 | |
| SCHEMBL9509255 | 0.92 | ACACB (0.54) | ACACBLMNAL3MBTL1KCNH2GAA | |
| SCHEMBL9511342 | 0.91 | ACACB (0.53) | ACACBLMNAL3MBTL1KCNH2GAA | |
| SCHEMBL9511346 | 0.89 | ACACB (0.48) | ACACB | |
| SCHEMBL9510199 | 0.88 | ACACB (0.51) | ACACBLMNAL3MBTL1 | |
| SCHEMBL10511210 | 0.88 | ACACB (0.43) | ACACBLMNAKCNH2HRH3 | |
| SCHEMBL9508786 | 0.86 | ACACB (0.48) | ACACBLMNAKCNH2 | |
| SCHEMBL9512380 | 0.85 | ACACB (0.47) | ACACBLMNAKCNH2 | |
| SCHEMBL9511288 | 0.85 | ACACB (0.47) | ACACBLMNAKCNH2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0308438-B1 | LIQUID CRYSTAL PHASE CONTAINING TOLANES | MERCK PATENT GmbH (DE) | 1993-09-29 | — | — | EP | disclosed |